SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

Shares are trending lower as investors react to increased volatility and market uncertainty surrounding the timing of the Phase 3 REGAL trial's endpoint. Sentiment is divided between long-term investors maintaining conviction in the clinical trial's potential and traders expressing frustration over the company's communication silence and the influence of unverified third-party models.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is trending following a sharp decline in share price as traders react to the company's recent Phase 3 clinical data for its lead drug sonelokimab and concerns regarding potential share dilution. While some investors remain optimistic about the drug's long-term commercial potential for hidradenitis suppurativa, others are expressing frustration with management's communication strategy and the lack of a definitive acquisition deal.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group is trending as the community debates the political implications of its primary shareholder's recent public appearances and campaign promises, including a proposal for a prosperity dividend. The conversation remains highly polarized, with intense disagreement over the company's financial stability, ongoing political controversies, and the broader impact of its associated brand.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers is trending as traders speculate on potential price action and future growth, particularly regarding upcoming peptide product launches and global expansion. Discussion is largely split between bullish investors anticipating a major breakout toward higher price levels and bears concerned about regulatory scrutiny and historical volatility.

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracle shares are facing significant downward pressure as investors react to a pre-scheduled stock-trading plan by Chairman Larry Ellison, despite the company reporting strong earnings and revenue growth. While bullish traders argue that the price drop is an overreaction to routine liquidity events and options-related volatility, many remain concerned about the company's heavy debt burden and the cash-flow impact of aggressive AI data center spending.

Oklo, Inc. engages in the development of fission reactors. It provides clean energy through the design and deployment of fast fission power plants. The company was founded by Jacob DeWitte and Caroline Cochran on July 3, 2013 and is headquartered in Santa Clara, CA.

Oklo Inc. - Ordinary Shares - Class A

Oklo Inc.

Oklo shares are trending primarily due to the launch of a new $1 billion at-the-market (ATM) share-sale program, which has intensified investor concerns regarding equity dilution. While some traders express frustration over the company's capital-raising strategy and ongoing insider selling, others remain bullish on the long-term outlook for nuclear energy in supporting AI-driven data center demand.

Listed Funds Trust - Roundhill Magnificent Seven ETF

Roundhill Magnificent Seven ETF

The Roundhill Magnificent Seven ETF is trending as traders closely monitor a rotation out of mega-cap tech into broader market sectors, fueled by concerns over stretched AI valuations and cooling investor appetite for the group. While some market participants express frustration over the underperformance of these names, others are debating whether current price levels represent a structural re-rating or an attractive buying opportunity for long-term investors.

Affirm Holdings, Inc. operates a platform for digital and mobile-first commerce. Its platform consists of three core elements: a point-of-sale payment solution for consumers, merchant commerce solutions, and a consumer-focused app. The company was founded by Max R. Levchin in 2012 and is headquartered in San Francisco, CA.

Affirm Holdings Inc - Ordinary Shares - Class A

Affirm Holdings Inc

Affirm is trending due to significant volatility following its latest quarterly earnings report, which triggered a range of analyst price target revisions and competing debates over the company's valuation, credit risk, and growth sustainability. While some traders view the recent price pullbacks as buying opportunities for a high-quality growth stock, others remain concerned about macroeconomic headwinds and the sustainability of its business model in a higher interest rate environment.

Circle Internet Group, Inc. is a financial technology company that enables businesses of all sizes to harness the power of digital currencies and public blockchains for payments, commerce and financial applications worldwide. The company was founded by Jeremy J. Allaire and Patrick Sean Neville in August 2013 and is headquartered in New York, NY.

Circle Internet Group Inc. - Ordinary Shares - Class A

Circle

NuScale Power Corp. provides proprietary and innovative advanced small modular reactor (SMR) nuclear technology, with a mission to help power the global energy transition by delivering safe, scalable, and reliable carbon-free energy. Its products include VOYGR SMR Plants and Energy Exploration (E2) Centers. The company was founded by José N. Reyes in 2007 and is headquartered in Corvallis, OR.

NuScale Power Corporation - Ordinary Shares - Class A

NuScale Power Corp

NuScale Power is trending following a downgrade by UBS, which cited concerns over a prolonged build timeline, limited customer commitments, and significant projected cash burn. While retail traders remain divided, with some viewing the downgrade as a tactical move by larger institutions and others expressing frustration over project execution, the stock faces continued pressure to secure binding commercial agreements to validate its long-term outlook.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$CYDY first ever Glioblastoma patient on Leronlimab.  Fight on brother! 🙏

LIVIMMUNE Bound

Thomas Smith

Lisa

doit4dale

Saucier

Gregory O'Donnell

Michael

skilachi19

Andrew

Robert

matt kelleher

Clark Kent

CJ Sigler

Tuna T

Maggie16

Zunilda Kings

Karen Schydlowski

MFSalvatore

Thomas Migliara

Zion

M. O. E.

Jane Sackler

Lonny Cummings

Tom Wright

Jay Magallon

StockTwits for iOS

CytoDyn Inc

 first ever Glioblastoma patient on Leronlimab.  Fight on brother! 🙏

Bio4

mitchmiller

S. Gerald

CGC Cassell

@Bio4 how’s the possible? Because it’s ran by the hospital?

 how’s the possible? Because it’s ran by the hospital?

Victor Trujillo

Anyon

StockTwits For Android 

@Bio4 amazing news! Thank you Bio4, I’m praying for Chan and LL -let’s gooooo!

Bread

 amazing news! Thank you Bio4, I’m praying for Chan and LL -let’s gooooo!

@Bio4 i think doctors can apply/submit for compassionate use??? praying for Chan! LL gonna change his life.

StockTwits Web

 i think doctors can apply/submit for compassionate use??? praying for Chan! LL gonna change his life.

Casey Young

Rod Schilz

@Bio4 
Now he is walking
No Walker 
No wheelchair
How fast did that happen?
Oh, only after just the very first dose

 
Now he is walking
No Walker 
No wheelchair
How fast did that happen?
Oh, only after just the very first dose

@Bio4 
spending time with friends &amp; family is not usually the preference of a patient with a growing brain tumor
Oh yeah, his is shrinking

 
spending time with friends & family is not usually the preference of a patient with a growing brain tumor
Oh yeah, his is shrinking

This is unbelievable! I live in Mississippi and am trying to connect with them. I have a first cousin who is also an investor in CYDY an lives in the same town! We will try to connect with them personally. The power of the internet....

@Bio4 this is a fantastic post thank you, let’s hope and pray he has a dramatic response. His tumor goes into remission and possibly disappears. God bless him.

 this is a fantastic post thank you, let’s hope and pray he has a dramatic response. His tumor goes into remission and possibly disappears. God bless him.